Bluenote builds generative AI tools tailored for the life sciences industry. Its platform is designed to automate regulatory and product lifecycle workflows, from preclinical research through clinical trials, manufacturing, and commercial stages. The company's technology targets a specific pain point in the sector: the time-intensive process of navigating regulatory requirements to bring new therapies and products to market.
The platform has been deployed in over 15 distinct applications serving scientists, engineers, and regulatory, quality, and manufacturing teams. According to the company, 90% of users preferred its specialized models over general-purpose, off-the-shelf alternatives. The stated goal is to accelerate regulatory submissions by 50-75%.
Bluenote's client base spans pharmaceutical firms, medical device companies, diagnostics providers, and contract research and development organizations (CROs and CDMOs). The company's technical focus sits at the intersection of generative AI and life sciences, applying large language models to domain-specific problems in regulatory workflow automation.
